Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an anthithrombotic therapeutic modality. The effect of low-dose aspirin is less than optimal in patients with vascular disease due to pro-thrombotic effects of erythrocytes on platelet reactivity - Valles, J; Santos, T; Aynar, J (Circulation, 1998)